Pemphigus Foliaceus Associated with Psoriasis during the Course of Narrow-Band UVB Therapy: A Simple Coincidence? by Kwon, Hyuck Hoon et al.
PF Associated with Psoriasis during NBUVB Therapy
Vol. 23, Suppl. 3, 2011 S281
Received July 21, 2010, Revised August 18, 2010, Accepted for 
publication August 18, 2010
Corresponding author: Jai Il Youn, M.D., Ph.D., Department of Der-
matology, Seoul National University College of Medicine, 28 Yeong-
eon-dong, Jongno-gu, Seoul 100-744, Korea. Tel: 82-2-2072-3274, 
Fax: 82-2-742-7344, E-mail: jaiil@snu.ac.kr
This is an Open Access article distributed under the terms of the 
Creative Commons Attribution Non-Commercial License (http:// 
creativecommons.org/licenses/by-nc/3.0) which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Ann Dermatol Vol. 23, Suppl. 3, 2011 http://dx.doi.org/10.5021/ad.2011.23.S3.S281
CASE REPORT
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Although psoriasis and bullous diseases are considered to be 
completely different disease entities, the literature has 
reported a few cases of psoriasis associated with bullous 
diseases, most of which are bullous pemphigoid. In limited 
cases, pemphigus foliaceus has also been reported in 
association with psoriasis. In most of them, pemphigus 
lesions usually developed on an untreated patient with a 
chronic history of psoriasis. Herein, we report a case of 
53-year-old male with a chronic history of psoriasis who first 
developed generalized erosive lesions after 26 cycles of 
narrow-band ultraviolet B (NBUVB) therapy. A diagnosis of 
pemphigus foliaceus was made based on skin biopsy and 
direct immunofluorescence assay. Pemphigus lesions were 
well controlled with combination therapy of oral steroid and 
azathioprine. This is the first case where pemphigus foli-
aceus co-occurred with psoriasis during NBUVB therapy. 
(Ann Dermatol 23(S3) S281∼S284, 2011)
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INTRODUCTION
Since the first report of Bloom
1 in 1929, the literature has 
reported a few cases of psoriasis coexistent with auto-
immune bullous diseases. Bullous pemphigoid is the most 
frequent association observed, while pemphigus foliaceus 
has been reported to be coexistent with psoriasis in a few 
cases
2-8. Whether the triggering stimuli imposed during 
psoriasis treatments or psoriasis itself is ultimately res-
ponsible for the induction of pemphigus has not been 
clearly elucidated. This is interesting, because possible 
pathogenic relations between pemphigus and psoriasis 
could be explained by a local microenvironment that fa-
vors a second autoimmune response. Herein, we report 
the first case of a patient with a chronic history of psoriasis 
who developed pemphigus foliaceus during narrow-band 
ultraviolet B (NBUVB) treatment. 
CASE REPORT
A 53-year-old male, who had suffered from psoriasis since 
the age of 40, was referred to our psoriasis clinic because 
topical steroids had not been at all effective. He had been 
treated with broad-band UVB phototherapy eight years 
prior for one month, and it was effective with no side 
effects. On physical exam, there were erythematous squa-
mous psoriatic plaques on the trunk, groin, and extensor 
side of the extremities (Fig. 1A). The initial Psoriasis Area 
and Severity Index score was 24.8. Laboratory investi-
gations were within normal limits except for hypercho-
lesterolemia (289 mg/dl) and erythrocyte sedimentation 
rate elevation (28 mm/h). NBUVB phototherapy was 
started from 500 mJ/cm
2, with a 20% dosage increment, 
and he received the cumulative dose of 65,960 mJ/cm
2 for HH Kwon, et al
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Fig. 1. (A) Typical nummular type 
psoriasis at patient’s initial visit. (B) 
Development of flaccid vesicles and
erosive lesions after receiving 26 
cycles of narrow-band ultraviolet B 
therapy (Total irradiation dose: 65, 
930 mJ).
Fig. 2. (A) Acantholysis of the upper
epidermis, moderate dermal infil-
tration of lymphocytes from erosive 
lesions (H&E, x200). (B) Direct im-
munofluorescence on perilesional 
tissue showing intercellular IgG de-
position.
two months. After the 26th treatment of phototherapy (UV 
dose: 3,960 mJ/cm
2), several erosive lesions were obser-
ved around the trunk and extensor surface of the arms 
(Fig. 1B). Nikolsky sign was positive. Phototherapy was 
discontinued, and skin biopsy performed from the erosive 
lesions showed acantholysis of the upper epidermis with 
moderate perivascular infiltration of lymphocytes and eo-
sinophils (Fig. 2). The direct immunofluorescence demon-
strated intercellular deposition of IgG. Another biopsy spe-
cimen from the erythematous squamous plaques revealed 
psoriasis vulgaris. Once diagnosed with the coexistence of 
pemphigus foliaceus and psoriasis vulgaris, the patient 
was treated with oral prednisolone (45 mg daily) and aza-
thioprine (100 mg daily). In the following four weeks after 
medication, almost complete remission of the erosive 
lesions was observed, and the patient has been main-
tained on a low dose of oral steroid and azathioprine.
DISCUSSION
Pemphigus foliaceus is an autoimmune blistering disorder 
characterized by granular layer acantholysis as a result of 
autoantibodies to a cell adhesion molecule, desmoglein 1. 
Compared with bullous pemphigoid and pemphigus 
vulgaris, only seven cases of pemphigus foliaceus coexi-
stent with psoriasis vulgaris have been reported in the 
English literature
2-8 (Table 1). Although the clinical fea-
tures of each case were somewhat different, we could find 
some notable points. First, pemphigus foliaceus developed 
on pre-existing psoriasis in six cases with the exception of 
a single case
2, where two diseases were found simul-
taneously. The period between appearance of psoriasis 
and pemphigus foliaceus varied from 8 months to 52 
years, depending on cases. In our case, pemphigus was 
observed after 13 years had passed since the initiation of 
psoriasis. Second, pemphigus foliaceus developed on un-
treated psoriasis in 6 out of a total of 7 patients. One PF Associated with Psoriasis during NBUVB Therapy
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Table 1. Information on patients with pemphigus foliaceus coexisting with psoriasis in English literature
No. Age/
Gender
Time gap between
psoriasis & PF
Treatment of
psoriasis when PF 
developed
Histology 
pattern*
Immunosuppressant
taken for PF lesions
PF
course Author
  1  34/F     Concurrent    
    evelopment 
None    Mixed Azathioprine
Prednisolone
Benign     Lee et al.
2  
  2   45/M     NA PUVA  Separate Prednisolone Benign     Aghassi and
     D o v e r
3
  3   72/M     52 yr None Separate Prednisolone Benign     Tomasini et al.
4
  4   38/M     NA  None Separate Methotrexate Benign     Perez et al.
5
  5   51/M     8 mo None Separate Prednisolone Benign     Yokoo et al.
6
  6  77/F     7 yr None Separate Prednisolone Benign     Giomi et al.
7
  7  40/F        10 yr  None Separate     MTX IM Benign     Lee and Ro
8
F: female, M: male, PF: pemphigus foliaceus, NA: not available, MTX: methotrexate, IM: intramuscular injection. *Mixed: histologic 
pattern of skin lesion showed intermingled traits of both psoriasis and PF, Separate: histologic pattern of skin lesion was dependent 
on the type of lesion chosen for biopsy.   
patient
3 developed pemphigus foliaceus during PUVA 
therapy, although the total amount of irradiation was not 
recorded in detail. In our case, the patient developed 
pemphigus foliaceus during NBUVB therapy, which has 
never been reported. Third, the histological patterns were 
dependent on the lesions chosen for biopsy in 6 out of 7 
patients. The psoriasis and pemphigus lesions of each 
patient demonstrated their characteristic histologies. Only 
one case
4 demonstrated an intermingled pattern. Last, the 
clinical course of pemphigus foliaceus was benign in all 
cases. Bullous lesions were soon improved after taking 
oral prednisolone or other immunosuppressive drugs in 
every report, including our case. 
Some cases of bullous pemphigoid and pemphigus 
vulgaris coexistent with psoriasis have been reported to be 
associated with PUVA or NBUVB treatment
9-12. While a 
previous report
13 demonstrated that NBUVB exposure of 
uninvolved skin of patients with fogo selvagem exacer-
bated acantholysis of the epidermis triggered by auto-
antibodies, this is the first case of UVB irradiation that 
might be directly associated with induction of pemphigus 
foliaceus in a patient suffering from psoriasis without pre-
vious history of bullous diseases. The pathogenesis might 
be partly understood in the context of “epitope spreading 
of autoimmune disease,” proposed by Chan et al.
14. It is 
probable that inflammatory processes triggered by 
NBUVB irradiation might have provided a microenvir-
onment for the epidermal exposure of desmoglein an-
tigens and facilitated interactions with a cutaneous im-
mune system. Excessive atypical lymphocytes of under-
lying psoriasis would raise the possibility of this secondary 
autoimmune reaction. We might also consider the role of 
genetics for susceptible patients, since HLA DRB1 alleles 
have been reported to be associated with both psoriasis
15 
and pemphigus foliaceus
16. Further genetic studies might 
help to elucidate the exact mechanism of this clinical 
observation.
We herein report a case of pemphigus foliaceus that was 
first observed during NBUVB therapy of psoriasis. We 
think that the diagnosis of pemphigus foliaceus should 
also be kept in mind for the skin erosions of psoriatic 
patients receiving NBUVB phototherapy. 
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